Clinical trial • Phase III • Haematology
IADADEMSTAT for Sickle cell disease
Phase III trial of IADADEMSTAT for Sickle cell disease. 30 participants.
Overview
- Trial Therapeutic Area
- Haematology
- Trial Disease
- Sickle cell disease
- Trial Stage
- Phase III
Key dates
- Initial CTIS Submission Date
- 15-05-2025
- First CTIS Authorization Date
- 20-08-2025
Trial design
Phase III trial across 7 sites in Spain.
- Target Sample Size
- 30
Recruitment
- Planned Sample Size
- 30
- Recruitment Window Months
- 891
Geography
- Total Number Of Sites
- 7
- Total Number Of Participants
- 30
Spain
- Earliest CTIS Part Ii Submission Date
- 16-07-2025
- Latest Decision Or Authorization Date
- 09-12-2025
- Processing Time Days
- 146
- Number Of Sites
- 7
- Number Of Participants
- 30
Sites
- Site Name
- Institut Catala D'oncologia
- Department Name
- Hematology
- Contact Person Name
- Ines Hernández
- Contact Person Email
- ihernandez@iconcologia.net
- Site Name
- Hospital Universitario La Paz
- Department Name
- Hematology
- Contact Person Name
- Ana Mendoza
- Contact Person Email
- anamendoz94@gmail.com
- Site Name
- Hospital De La Santa Creu I Sant Pau
- Department Name
- Hematology
- Contact Person Name
- Nuria González
- Contact Person Email
- NGonzalezAl@santpau.cat
- Site Name
- Hospital Clínic Barcelona
- Department Name
- Hematology
- Contact Person Name
- Meritxell Nomdedeu
- Contact Person Email
- MNOMDEDEU@clinic.cat
- Site Name
- Hospital General Universitario Gregorio Maranon
- Department Name
- Hematology
- Contact Person Name
- Cristina Pascual
- Contact Person Email
- cpascuali@salud.madrid.org
- Site Name
- Hospital Universitari Vall D Hebron
- Department Name
- Hematology
- Contact Person Name
- David Beneitez
- Contact Person Email
- david.beneitez@vallhebron.cat
- Site Name
- University Hospital Virgen Del Rocio S.L.
- Department Name
- Hematology
- Contact Person Name
- Salvador Payán
- Contact Person Email
- salvador.payan.sspa@juntadeandalucia.es
Sponsor
Primary sponsor
- Full Name
- Oryzon Genomics S.A.
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Spain
Investigational products
- Investigational Product Name
- IADADEMSTAT
Related trials
Other published trials that may interest you.